The US president’s threatened war lacks a clear objective or a plan

Western democracies need a strategy for engaging with the Board of Peace

Uncertainty will linger as the president tests alternative legal options

When the Swedish fintech grows rapidly, short-term income goes down — as have its shares

The chipmaker may hope Meta’s endorsement will attract other hyperscalers

Big pharma has emerged from its 2025 paralysis with plenty of firepower